Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Non-pharmacological Treatment
100%
Indonesia
14%
Inflammation
14%
Liver Disease
14%
Oxidative Stress
14%
Alcohol
14%
Disease Pathogenesis
14%
Increased Incidence
14%
Vitamin E
14%
Free Fatty Acids
14%
Insulin Resistance
14%
Liver Cirrhosis
14%
Definitive Treatment
14%
Metformin
14%
Oxidative Inflammation
14%
Fibrosis
14%
Statins
14%
Insulin Sensitivity
14%
Physical Activity
14%
Metabolic Disorders
14%
Non-pharmacological
14%
Insulin Sensitizers
14%
Calories
14%
Omega-3
14%
Steatosis
14%
Losartan
14%
Lifestyle Intervention
14%
Ursodeoxycholic Acid
14%
Orlistat
14%
Bariatric Surgery
14%
Pharmacologic Interventions
14%
Low Sugar
14%
Pentoxyphylline
14%
Low Saturated Fat
14%
Hepatocyte Death
14%
Fatty Acid Accumulation
14%
Hepatocyte Proliferation
14%
Glitazones
14%
Sugar Diet
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Inflammation
28%
Disease
14%
Deterioration
14%
Liver Disease
14%
Prevalence
14%
Fatty Acid
14%
Alpha Tocopherol
14%
Insulin Resistance
14%
Liver Cirrhosis
14%
Metformin
14%
Ethanol
14%
Fibrosis
14%
Statin (Protein)
14%
Metabolic Disorder
14%
Saturated Fatty Acid
14%
Steatosis
14%
Omega-3 Fatty Acid
14%
Insulin Sensitizing Agent
14%
Losartan
14%
Ursodeoxycholic Acid
14%
Tetrahydrolipstatin
14%
Pentoxifylline
14%
Glitazone Derivative
14%